Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial.

Source:http://linkedlifedata.com/resource/pubmed/id/19039248

Download in:

View as

General Info

PMID
19039248